| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
135 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
81 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
32 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
116 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
193 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
52 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
182 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
230 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
38 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
70 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
401 |
| 424/264.1 |
Mycoplasma |
64 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
132 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
107 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
95 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
116 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
177 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
169 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
399 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
519 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
122 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
46 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
102 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6676942 |
Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
Jan. 13, 2004 |
| 6676943 |
Human complement C3-degrading protein from Streptococcus pneumoniae |
Jan. 13, 2004 |
| 6673353 |
Tuberculosis vaccine |
Jan. 6, 2004 |
| 6673356 |
Compounds and methods for the diagnosis and treatment of ehrlichia infection |
Jan. 6, 2004 |
| 6669940 |
Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof |
Dec. 30, 2003 |
| 6669944 |
Process for the preparation of an extract with carotenoids, UV absorption, antibacterial and pH indicating properties from a deep-sea bacterium |
Dec. 30, 2003 |
| 6667038 |
Prevention, diagnosis and treatment of lyme disease |
Dec. 23, 2003 |
| 6667040 |
Bovine footrot treatment and prevention |
Dec. 23, 2003 |
| 6663873 |
Antigenic preparation for treatment or prevention of helicobacter infection |
Dec. 16, 2003 |
| 6664094 |
Neisserial vaccine free of immunologically functional PIII or class 4 proteins |
Dec. 16, 2003 |
| 6664096 |
Methods for improved diagnosis and treatment of mycobacterial infections |
Dec. 16, 2003 |
| 6660261 |
Bordetella strain expressing the FHA hybrid, liposomes and vaccines |
Dec. 9, 2003 |
| 6660269 |
Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
Dec. 9, 2003 |
| 6660274 |
Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
Dec. 9, 2003 |
| 6660840 |
Methods for enhancement of protective immune responses |
Dec. 9, 2003 |
| 6656477 |
43 Kd protein vaccine and method for the production thereof |
Dec. 2, 2003 |
| 6656478 |
Cross-protective salmonella vaccines |
Dec. 2, 2003 |
| 6649170 |
Adjuvant combinations for immunization composition and vaccines |
Nov. 18, 2003 |
| 6649171 |
Moraxella catarrahalis polynucleotides and polypeptides |
Nov. 18, 2003 |
| 6649172 |
Amphipathic aldehydes and their uses as adjuvants and immunoeffectors |
Nov. 18, 2003 |
| 6645497 |
Polynucleotide compositions encoding broad-spectrum .delta. endotoxins |
Nov. 11, 2003 |
| 6645503 |
Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria |
Nov. 11, 2003 |
| 6645515 |
Bacteriostatic composition for salmonellae |
Nov. 11, 2003 |
| 6642354 |
Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
Nov. 4, 2003 |
| 6638510 |
Recombinant plasmid and a method of controlling the effects of Yersinia pestis |
Oct. 28, 2003 |
| 6638511 |
Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
Oct. 28, 2003 |
| 6638513 |
Neisseria meningitidis serogroup B Glycoconjugates |
Oct. 28, 2003 |
| 6638515 |
Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using protein V |
Oct. 28, 2003 |
| 6635247 |
Hypoparathyroid therapy |
Oct. 21, 2003 |
| 6635260 |
Methods and compositions for prevention and treatment of Clostridium difficile-associated diseases |
Oct. 21, 2003 |
| 6635261 |
Adjuvant and vaccine compositions containing monophosphoryl lipid A |
Oct. 21, 2003 |
| 6632434 |
Leptospiral major outer membrane protein, LipL 32 |
Oct. 14, 2003 |
| 6632439 |
Fusobacterium necrophorum vaccine and method for making such vaccine |
Oct. 14, 2003 |
| 6632441 |
Mutants of streptococcal toxin a and methods of use |
Oct. 14, 2003 |
| 6630147 |
Pseudomycin natural products |
Oct. 7, 2003 |
| 6630582 |
Treatment and prevention of helicobacter infection |
Oct. 7, 2003 |
| 6627203 |
Renibacterium salmoninarum vaccine |
Sep. 30, 2003 |
| 6623739 |
Vaccines |
Sep. 23, 2003 |
| 6620415 |
Parkinson's disease treatment |
Sep. 16, 2003 |
| 6613321 |
Live vaccines against gram-negative pathogens, expressing heterologous O-antigens |
Sep. 2, 2003 |
| 6613331 |
Vaccine against Lyme disease |
Sep. 2, 2003 |
| 6613335 |
Polypeptides from moraxella (branhamella) catarrhalis |
Sep. 2, 2003 |
| 6610300 |
Clostridium perfringens vaccine |
Aug. 26, 2003 |
| 6610301 |
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines |
Aug. 26, 2003 |
| 6610306 |
OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof |
Aug. 26, 2003 |
| 6610307 |
Immunity against pasteurella haemolytica leukotoxin |
Aug. 26, 2003 |
| 6610517 |
Compartmentalization of recombinant polypeptides in host cells |
Aug. 26, 2003 |
| 6607725 |
Conjugate vaccine for nontypeable Haemophilus influenzae |
Aug. 19, 2003 |
| 6607728 |
Compounds and methods for the diagnosis and treatment of ehrlichia infection |
Aug. 19, 2003 |
| 6607729 |
Surface antigen |
Aug. 19, 2003 |
|
|
|
